Cite
MLA Citation
Paolo Ghia et al.. “Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results.” HemaSphere, vol. 6, no. 12, 2022, pp. e801–. http://access.bl.uk/ark:/81055/vdc_100171887179.0x000002